This has even been termed the quarter fat-free mass rule. So, if GLP-1 interventions cause ~40% of weight loss as lean mass vs ~25% due to lifestyle, then GLP-1-based interventions are at least associated with disproportionate muscle mass loss
Kidney Int (2022) 102(2):293306
Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis: from pathophysiology to clinical practice
8991 While DPP4 inhibitors have been extensively used in the treatment of type 2 diabetes mellitus (T2DM) for over a decade, their efficacy in T1DM remains uncertain
Its one of the most popular peptides in performance medicine, longevity therapy, and musculoskeletal regeneration
Kefirs protein and nutrients stimulate postprandial GLP-1 release, while probiotics and bioactive peptides influence the integrity of the gut barrier to increase the production of butyrate levels (short chain fatty acids)